Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial

Autor: Nikolaj Ihlemann, Peter Clemmensen, Lars Søndergaard, Thomas Engstrøm, Peter Skov Olsen, Bo Juel Kjeldsen, Petur Petursson, Daniel A Steinbrüchel, Henrik Nissen, Olaf Walter Franzen, Anh Thuc Ngo, Hans Gustav Hørsted Thyregod, Yanping Chang, Niels Thue Olsen
Rok vydání: 2015
Předmět:
Aortic valve
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Denmark
Myocardial Infarction
Kaplan-Meier Estimate
030204 cardiovascular system & hematology
hemodynamics
Risk Assessment
Severity of Illness Index
law.invention
Transcatheter Aortic Valve Replacement
03 medical and health sciences
0302 clinical medicine
Valve replacement
Aortic valve replacement
Randomized controlled trial
law
Risk Factors
Internal medicine
medicine
Risk of mortality
Humans
030212 general & internal medicine
Proportional Hazards Models
Heart Valve Prosthesis Implantation
Sweden
bioprosthesis
business.industry
Hemodynamics
Aortic Valve Stenosis
medicine.disease
stroke
Confidence interval
Surgery
Clinical trial
Stroke
myocardial infarction
medicine.anatomical_structure
Treatment Outcome
Echocardiography
Aortic valve stenosis
Aortic Valve
Heart Valve Prosthesis
Cardiology
transcatheter aortic valve replacement
Cardiology and Cardiovascular Medicine
business
Zdroj: Søndergaard, L, Steinbrüchel, D A, Ihlemann, N, Nissen, H, Kjeldsen, B J, Petursson, P, Ngo, A T, Olsen, N T, Chang, Y, Franzen, O W, Engstrøm, T, Clemmensen, P, Olsen, P S & Thyregod, H G H 2016, ' Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement : The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial ', Circulation: Cardiovascular Interventions, vol. 9, no. 6, e003665 . https://doi.org/10.1161/CIRCINTERVENTIONS.115.003665
ISSN: 1941-7632
DOI: 10.1161/CIRCINTERVENTIONS.115.003665
Popis: Background— The Nordic Aortic Valve Intervention (NOTION) trial was the first to randomize all-comers with severe native aortic valve stenosis to either transcatheter aortic valve replacement (TAVR) with the CoreValve self-expanding bioprosthesis or surgical aortic valve replacement (SAVR), including a lower-risk patient population than previous trials. This article reports 2-year clinical and echocardiographic outcomes from the NOTION trial. Methods and Results— Two-hundred eighty patients from 3 centers in Denmark and Sweden were randomized to either TAVR (n=145) or SAVR (n=135) with follow-up planned for 5 years. There was no difference in all-cause mortality at 2 years between TAVR and SAVR (8.0% versus 9.8%, respectively; P =0.54) or cardiovascular mortality (6.5% versus 9.1%; P =0.40). The composite outcome of all-cause mortality, stroke, or myocardial infarction was also similar (15.8% versus 18.8%, P =0.43). Forward-flow hemodynamics were improved following both procedures, with effective orifice area significantly more improved after TAVR than SAVR (effective orifice area, 1.7 versus 1.4 cm 2 at 3 months). Mean valve gradients were similar after TAVR and SAVR. When patients were categorized according to Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) (P =0.58) or intermediate-risk patients (21.1% versus 27.1%; P =0.59). Conclusions— Two-year results from the NOTION trial demonstrate the continuing safety and effectiveness of TAVR in lower-risk patients. Longer-term data are needed to verify the durability of this procedure in this patient population. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT01057173.
Databáze: OpenAIRE